查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933351

全球抗生物膜製剂市场：市场规模、占有率、成长率、产业分析、类型、应用和地区因素及未来预测（2026-2034）

Anti-Biofilm Agents Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 请询问到货日

价格

抗生物膜製剂市场成长因素

受急性和慢性伤口日益增多以及生物膜相关感染负担加重的推动，全球抗生物膜製剂市场正经历稳定成长。根据 Fortune Business Insights 的一项研究显示，2025 年全球抗生物膜製剂市场规模将达到 15 亿美元。预计该市场将从 2026 年的 16.4 亿美元成长到 2034 年的 32.1 亿美元，预测期内复合年增长率 (CAGR) 为 8.79%。北美地区凭藉先进的伤口护理基础设施和对生物膜管理的高度重视，在 2025 年将以 36.49% 的市场占有率领先。

抗生物膜製剂是旨在预防、破坏和控制生物膜的产品。生物膜是由微生物在其自身产生的基质内所形成的结构化菌落。生物膜常见于慢性伤口，并透过增加对抗生素和免疫反应的抗药性而显着延缓伤口癒合。根据MDPI 2024年的数据，约60%的慢性伤口和约10%的急性伤口会形成生物膜，这凸显了临床上对有效抗生物膜解决方案日益增长的需求。

市场动态

市场驱动因素

急性和慢性伤口数量的增加是市场成长的主要驱动因素。糖尿病足溃疡、压疮、静脉性腿部溃疡、手术伤口和烧伤等病症被认为是生物膜形成的高风险区域。 例如，根据美国国家生物技术资讯中心 (NCBI) 2023 年的数据，全球糖尿病足溃疡的盛行率约为 6.3%。此外，医院获得性压疮仍然令人担忧，据估计，英国住院患者的压疮发生率为 8.7%。这些趋势正在推动对先进伤口护理和抗生物膜产品的需求。

市场限制因子

发展中国家的诊断和治疗率低，限制了市场成长。转诊延迟、缺乏临床专业知识、缺乏认知以及缺乏标准化指南，常常促使慢性伤口诊断延迟。 2023 年发表的一项研究报告称，糖尿病足溃疡患者从症状出现到接受专科医生评估的平均延迟时间为 15 至 126 天。这些延迟阻碍了抗生物膜药物的及时应用，尤其是在印度、中国和巴西等新兴市场。

市场机会

各大公司研发投入的增加带来了巨大的成长机会。各公司正大力投资临床试验和产品创新，以开发具有增强抗生物膜性能的先进敷料、凝胶和粉末。例如，2024年5月，康维特公司报告其AQUACEL Ag+Extra敷料在治疗静脉性腿部溃疡方面取得了积极的临床结果。政府主导的伤口护理意识提升计画的增加，也进一步推动了市场扩张。

市场挑战

生物膜预防和控制指南的执行情况不佳仍然是一个挑战，尤其是在发展中地区。医护人员和患者缺乏相关意识促使伤口照护不足，进一步加剧了生物膜的传播。此外，先进抗生物膜产品的高昂成本限制了其在註重成本的医疗系统中的应用。

抗生物膜市场趋势

新型抗生物膜产品的推出是市场的主要趋势。研究人员正在积极探索奈米技术、奈米药物递送系统以及抗菌奈米颗粒（例如银和氧化锌），以提高生物膜的渗透性和破坏性。评估这些先进技术的临床试验预计将在预测期内提高产品疗效并推动市场需求。

细分市场分析

依产品类型划分，敷料将在2026年占市场主导地位，市占率达67.86%。这主要归功于敷料在预防细菌污染和控制生物膜方面的有效性。

依分子类型划分，银类产品将在2026年占市场主导地位，市占率达47.62%。这主要归功于银的广谱抗菌活性。

依伤口类型划分，慢性伤口将在2026年占68.15%的市场。这主要受糖尿病足溃疡和压疮高发生率的驱动。

依最终用户划分，医院将在2026年占43.12%的市场占有率，成为市场主导力量，这反映了医院较高的住院率以及获得先进伤口护理解决方案的机会。

区域展望

北美预计将引领市场，在强劲的医疗保健支出和产品创新推动下，2025年市场规模将达到5.5亿美元，2026年将达到5.9亿美元。

欧洲预计将保持稳定成长，这得益于其完善的医疗保健体系和不断提高的健康意识。

亚太地区预计将实现最快的成长速度，这主要受伤口盛行率上升和研究活动扩展的推动。

由于可支配收入增加、医疗基础设施改善以及人们对伤口管理的认识不断提高，预计拉丁美洲、中东和非洲地区将出现增长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家主要疾病盛行率（2025/2025）
  • 主要产业趋势：併购、业务合作
  • 产品供应：抗生物膜剂、主要参与者

第五章：全球抗生物膜剂市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品分类
    • 敷料
    • 软膏/凝胶
    • 粉剂
  • 市场分析、洞察与预测：依分子分类
    • 银
    • 碘
    • 蜂蜜
    • 其他
  • 市场分析、洞察与预测：依伤口类型分类
    • 慢性伤口
    • 急性伤口
  • 市场分析、洞察与预测：依最终用户分类
    • 医院
    • 伤口诊所
    • 家庭医疗保健
    • 其他
  • 市场分析、洞察与预测：依地区分类
    • 北部美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美抗生物膜剂市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲抗生物膜剂市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他欧洲国家

第八章 亚太地区抗生物膜剂市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲抗生物膜剂市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲抗生物膜剂市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会（GCC）国家
    • 南亚非洲
    • 中东和非洲其他地区

第11章 竞争分析

  • 世界市场占有率分析(2025年)
  • 企业简介
    • Convatec Inc.
    • Smith+Nephew
    • Coloplast A/S
    • Solventum
    • Molnlycke AB
    • URGO MEDICAL
    • Imbed Biosciences
Product Code: FBI113668

Growth Factors of anti-biofilm agents Market

The global anti-biofilm agents market is witnessing steady growth, driven by the rising prevalence of acute and chronic wounds and the increasing burden of biofilm-associated infections. According to Fortune Business Insights, the global anti-biofilm agents market was valued at USD 1.5 billion in 2025. The market is projected to grow from USD 1.64 billion in 2026 to USD 3.21 billion by 2034, exhibiting a CAGR of 8.79% during the forecast period. North America dominated the market with a share of 36.49% in 2025, supported by advanced wound care infrastructure and higher awareness of biofilm management.

Anti-biofilm agents are products designed to prevent, disrupt, or manage biofilms, which are structured communities of microorganisms embedded within a self-produced matrix. Biofilms are commonly found in chronic wounds and significantly delay healing by increasing resistance to antibiotics and immune responses. According to data published by MDPI in 2024, biofilm formation occurs in approximately 60% of chronic wounds and 10% of acute wounds, highlighting the growing clinical need for effective anti-biofilm solutions.

Market Dynamics

Market Drivers

The increasing prevalence of acute and chronic wounds is a primary driver of market growth. Conditions such as diabetic foot ulcers, pressure ulcers, venous leg ulcers, surgical wounds, and burn injuries are associated with a high risk of biofilm formation. For instance, data published by the National Center for Biotechnology Information in 2023 reported that the global prevalence of diabetic foot ulcers is around 6.3%. Additionally, hospital-acquired pressure ulcers remain a concern, with studies estimating an incidence of 8.7% among hospitalized patients in the U.K. These trends are driving the demand for advanced wound care and anti-biofilm products.

Market Restraints

Limited diagnosis and treatment rates in developing countries are restraining market growth. Delayed referrals, lack of clinical expertise, insufficient awareness, and absence of standardized guidelines often result in delayed diagnosis of chronic wounds. Studies published in 2023 reported delays ranging from 15 to 126 days from symptom onset to specialist assessment in patients with diabetic foot ulcers. These delays reduce timely adoption of anti-biofilm agents, particularly in emerging markets such as India, China, and Brazil.

Market Opportunities

Growing research and development activities among key players present significant growth opportunities. Companies are investing heavily in clinical trials and product innovation to introduce advanced dressings, gels, and powders with enhanced anti-biofilm properties. For example, in May 2024, Convatec Inc. reported positive clinical outcomes for its AQUACEL Ag+ Extra dressing in managing venous leg ulcers. Increasing government initiatives to improve wound care awareness further support market expansion.

Market Challenges

Limited adherence to biofilm prevention and management guidelines remains a challenge, particularly in developing regions. Low awareness among healthcare providers and patients leads to improper wound care practices, increasing the prevalence of biofilms. Additionally, the high cost of advanced anti-biofilm products restricts their adoption in cost-sensitive healthcare systems.

Anti-Biofilm Agents Market Trends

The introduction of novel anti-biofilm products is a key market trend. Researchers are increasingly exploring nanotechnology, nano-drug delivery systems, and antimicrobial nanoparticles such as silver and zinc oxide to improve biofilm penetration and disruption. Clinical studies evaluating these advanced technologies are expected to enhance product efficacy and boost demand during the forecast period.

Segmentation Analysis

By product, dressings dominated the market, accounting for 67.86% share in 2026, driven by their effectiveness in preventing bacterial contamination and managing biofilms.

By molecule, the silver segment led the market with a 47.62% share in 2026, owing to its broad-spectrum antimicrobial activity.

By wound type, chronic wounds accounted for 68.15% of the market in 2026, supported by the high prevalence of diabetic foot ulcers and pressure ulcers.

By end user, hospitals dominated with a 43.12% share in 2026, reflecting higher hospitalization rates and access to advanced wound care solutions.

Regional Outlook

North America led the market with a valuation of USD 0.55 billion in 2025 and USD 0.59 billion in 2026, supported by strong healthcare expenditure and product innovation.

Europe is expected to grow steadily due to established healthcare systems and rising awareness.

Asia Pacific is projected to register the fastest growth, driven by increasing wound prevalence and expanding research activities.

Latin America and the Middle East & Africa are expected to grow due to rising disposable incomes, healthcare infrastructure development, and increasing awareness of wound management.

Competitive Landscape

The market is moderately consolidated, with key players such as Smith+Nephew, Convatec Inc., and Coloplast A/S holding significant shares. These companies focus on product launches, clinical research, collaborations, and geographic expansion to strengthen their market position. Other notable players include Molnlycke AB, URGO MEDICAL, Solventum, and Imbed Biosciences.

Conclusion

The global anti-biofilm agents market is set for consistent growth over the forecast period, driven by the rising prevalence of chronic and acute wounds, increasing awareness of biofilm-associated complications, and continuous advancements in wound care technologies. With the market valued at USD 1.5 billion in 2025, projected to grow to USD 1.64 billion in 2026 and reach USD 3.21 billion by 2034, sustained R&D investments, innovation in antimicrobial technologies, and expanding healthcare infrastructure are expected to support long-term market expansion despite challenges related to cost, awareness, and guideline adherence.

Segmentation

By Product

  • Dressings
  • Ointments / Gels
  • Powders

By Molecule

  • Silver
  • Iodine
  • Honey
  • Others

By Wound Type

  • Chronic Wounds
  • Acute Wounds

By End User

  • Hospitals
  • Wound Clinics
  • Home Care Settings
  • Others

By Region

  • North America (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • U.S.
    • Canada
  • Europe (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, Key Countries, 2025/2025
  • 4.2. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.3. Detailed Product Offerings: Anti-biofilm Agents, Key Players

5. Global Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Dressings
    • 5.1.2. Ointments / Gels
    • 5.1.3. Powders
  • 5.2. Market Analysis, Insights and Forecast - By Molecule
    • 5.2.1. Silver
    • 5.2.2. Iodine
    • 5.2.3. Honey
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Wound Type
    • 5.3.1. Chronic Wounds
    • 5.3.2. Acute Wounds
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals
    • 5.4.2. Wound Clinics
    • 5.4.3. Homecare Settings
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Dressings
    • 6.1.2. Ointments / Gels
    • 6.1.3. Powders
  • 6.2. Market Analysis, Insights and Forecast - By Molecule
    • 6.2.1. Silver
    • 6.2.2. Iodine
    • 6.2.3. Honey
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Wound Type
    • 6.3.1. Chronic Wounds
    • 6.3.2. Acute Wounds
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals
    • 6.4.2. Wound Clinics
    • 6.4.3. Homecare Settings
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Dressings
    • 7.1.2. Ointments / Gels
    • 7.1.3. Powders
  • 7.2. Market Analysis, Insights and Forecast - By Molecule
    • 7.2.1. Silver
    • 7.2.2. Iodine
    • 7.2.3. Honey
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Wound Type
    • 7.3.1. Chronic Wounds
    • 7.3.2. Acute Wounds
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals
    • 7.4.2. Wound Clinics
    • 7.4.3. Homecare Settings
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Russia
    • 7.5.7. Rest of Europe

8. Asia Pacific Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Dressings
    • 8.1.2. Ointments / Gels
    • 8.1.3. Powders
  • 8.2. Market Analysis, Insights and Forecast - By Molecule
    • 8.2.1. Silver
    • 8.2.2. Iodine
    • 8.2.3. Honey
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Wound Type
    • 8.3.1. Chronic Wounds
    • 8.3.2. Acute Wounds
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals
    • 8.4.2. Wound Clinics
    • 8.4.3. Homecare Settings
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. China
    • 8.5.2. India
    • 8.5.3. Japan
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Dressings
    • 9.1.2. Ointments / Gels
    • 9.1.3. Powders
  • 9.2. Market Analysis, Insights and Forecast - By Molecule
    • 9.2.1. Silver
    • 9.2.2. Iodine
    • 9.2.3. Honey
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Wound Type
    • 9.3.1. Chronic Wounds
    • 9.3.2. Acute Wounds
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals
    • 9.4.2. Wound Clinics
    • 9.4.3. Homecare Settings
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle Est & Africa Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Dressings
    • 10.1.2. Ointments / Gels
    • 10.1.3. Powders
  • 10.2. Market Analysis, Insights and Forecast - By Molecule
    • 10.2.1. Silver
    • 10.2.2. Iodine
    • 10.2.3. Honey
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Wound Type
    • 10.3.1. Chronic Wounds
    • 10.3.2. Acute Wounds
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals
    • 10.4.2. Wound Clinics
    • 10.4.3. Homecare Settings
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Convatec Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Smith+Nephew
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Coloplast A/S
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Solventum
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Molnlycke AB
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. URGO MEDICAL
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Imbed Biosciences
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2021-2034
  • Table 3: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2021-2034
  • Table 4: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 5: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 7: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2021-2034
  • Table 8: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2021-2034
  • Table 9: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 10: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 12: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2021-2034
  • Table 13: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2021-2034
  • Table 14: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 15: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 17: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2021-2034
  • Table 18: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2021-2034
  • Table 19: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 20: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 22: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2021-2034
  • Table 23: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2021-2034
  • Table 24: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 25: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 27: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2021-2034
  • Table 28: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2021-2034
  • Table 29: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 30: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Anti-biofilm Agents Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Anti-biofilm Agents Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Anti-biofilm Agents Segmental Opportunity Index, By Product, 2025
  • Figure 4: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By Product, 2025 & 2034
  • Figure 5: Global Anti-biofilm Agents Market Value Share (%), by Molecule, 2025 & 2034
  • Figure 6: Global Anti-biofilm Agents Segmental Opportunity Index, By Molecule, 2025
  • Figure 7: Global Anti-biofilm Agents Segmental Opportunity Index, By Molecule, 2025
  • Figure 8: Global Anti-biofilm Agents Market Value Share (%), by Wound Type, 2025 & 2034
  • Figure 9: Global Anti-biofilm Agents Segmental Opportunity Index, By Wound Type, 2025
  • Figure 10: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By Wound Type, 2025 & 2034
  • Figure 11: Global Anti-biofilm Agents Market Value Share (%), by End User, 2025 & 2034
  • Figure 12: Global Anti-biofilm Agents Segmental Opportunity Index, By End User, 2025
  • Figure 13: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By End User, 2025 & 2034
  • Figure 14: Global Anti-biofilm Agents Market Value Share (%), by Region, 2025 & 2034
  • Figure 15: Global Anti-biofilm Agents Segmental Opportunity Index, By Region, 2025
  • Figure 16: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By Region, 2025 & 2034
  • Figure 17: North America Anti-biofilm Agents Market Value (USD billion), by Product, 2025 & 2034
  • Figure 18: North America Anti-biofilm Agents Market Value Share (%), by Product, 2025
  • Figure 19: North America Anti-biofilm Agents Market Value (USD billion), by Molecule, 2025 & 2034
  • Figure 20: North America Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2025 & 2034
  • Figure 21: North America Anti-biofilm Agents Market Value (USD billion), by End User, 2025 & 2034
  • Figure 22: North America Anti-biofilm Agents Market Value (USD billion), By Country, 2025 & 2034
  • Figure 23: Europe Anti-biofilm Agents Market Value (USD billion), by Product, 2025 & 2034
  • Figure 24: Europe Anti-biofilm Agents Market Value Share (%), by Product, 2025
  • Figure 25: Europe Anti-biofilm Agents Market Value (USD billion), by Molecule, 2025 & 2034
  • Figure 26: Europe Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2025 & 2034
  • Figure 27: Europe Anti-biofilm Agents Market Value (USD billion), by End User, 2025 & 2034
  • Figure 28: Europe Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by Product, 2025 & 2034
  • Figure 30: Asia Pacific Anti-biofilm Agents Market Value Share (%), by Product, 2025
  • Figure 31: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by Molecule, 2025 & 2034
  • Figure 32: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2025 & 2034
  • Figure 33: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by End User, 2025 & 2034
  • Figure 34: Asia Pacific Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 35: Latin America Anti-biofilm Agents Market Value (USD billion), by Product, 2025 & 2034
  • Figure 36: Latin America Anti-biofilm Agents Market Value Share (%), by Product, 2025
  • Figure 37: Latin America Anti-biofilm Agents Market Value (USD billion), by Molecule, 2025 & 2034
  • Figure 38: Latin America Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2025 & 2034
  • Figure 39: Latin America Anti-biofilm Agents Market Value (USD billion), by End User, 2025 & 2034
  • Figure 40: Latin America Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 41: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by Product, 2025 & 2034
  • Figure 42: Middle East & Africa Anti-biofilm Agents Market Value Share (%), by Product, 2025
  • Figure 43: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by Molecule, 2025 & 2034
  • Figure 44: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2025 & 2034
  • Figure 45: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by End User, 2025 & 2034
  • Figure 46: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 47: Global Anti-biofilm Agents Market Share (%), By Company, 2025